verified SJR 1,022 · Q1 • database Scopus / SJR & Web of Science indexed

South Korea · Korean Society of Gynecologi...

workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

Journal of Gynecologic Oncology

Journal of Gynecologic Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Obstetrics and Gynecology with an H index of 56. It has an SJR impact factor of 1,022 and it has a best quartile of Q1. It has an SJR impact factor of 1,022.

ISSN: 2005-0380

Publisher: Korean Society of Gynecologic Oncology and Colposcopy

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,022 Q1

H-index 56

Acceptance rate pie_chart

32%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,022

H-index

Docs (year)

113

Docs 3y

262

Total refs

3160

Cites 3y

768

Citable 3y

226

Cites/Doc 2y

3.18

Ref/Doc

27.96

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical and health policy experiences with HPV prevalence within the Hungarian organized cervical cancer screening program

Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates

Do we need a better marker for successful ovarian cancer surgery?

Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer

Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system

Diagnostic value of integrated 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients

Computed tomography-based quantitative assessment of lower extremity lymphedema following treatment for gynecologic cancer

Comparison between L and E gene amplification analytical methods for human papillomavirus typing

Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis

Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08)

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis

SHOW MORE ARTICLES

Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases

A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study

Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients

Characterizing the efficacy and trends of adjuvant therapy versus observation in women with early stage (uterine confined) leiomyosarcoma: a National Cancer Database study

Burden of cervical neoplasia in mid-western rural Nepal: a population-based study

BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling

ASGO 4th International Workshop on Gynecologic Oncology

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer

Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?

An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)

Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes

FAQs

Journal of Gynecologic Oncology has an SJR of 1,022 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Gynecologic Oncology is 32%.

Journal of Gynecologic Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Gynecologic Oncology?

What is the APC / publication cost?

What is the acceptance rate?